Phosphorus Oxychloride

Biographical Sketches

Fabien Caillé was born in 1986 in Tours, France. He graduated from the National Polytechnic School of Chemical Engineering and Technology of Toulouse in 2008 and is currently doing his PhD studies under the supervision of the Dr. F. Suzenet and the Dr. É. Jakab Tóth. His work deals with the synthesis and characterization of new bimodal probes for magnetic resonance and optical imaging.

Introduction

<P>Phosphorus oxychloride (POCl₃) is a common and intensively used inorganic compound industrially prepared from phosphorus trichloride either by oxidation with oxygen or chlorination followed by treatment with phosphorus pentoxide (Scheme  [¹] ). Despite it reacts violently with water, this stable colorless liquid has been extensively studied for decades to promote the synthesis of diverse heterocycles, [¹] such as the Bischler-Napieralski formation of isoquinolines [²] and its related cyclisations [³] , the Meth-Cohn approach to quinolines [4] or the Robinson-Gabriel route to oxazole. [5] Beyond the heterocyclic chemistry, phosphorus oxychloride is a powerful reagent for various functionalization like chlorinations, [6] Vilsmeier-Haack formylations [7] or dehydratations. [8] POCl₃ also appears as a key reagent in bioorganic chemistry to phosphorylate proteins [9] or nucleosides, [¹0] and enters in the preparation of some polymers. [¹¹] </P>

Scheme 1  Industrial preparation of phosphorus oxychloride

Abstracts

<TD VALIGN="TOP"> (A) An efficient one-pot synthesis of a library of 1-arylpyrazolo[3,4-d]pyrimidin-4-ones 2 has been reported. [¹²] Phosphorus oxychloride acts both as a chlorinating agent and an oxidant to generate in situ the reactive carboxamide and the acyl chloride. Intramolecular condensation thus afforded the targeted heterocycles 2 in high yields (70-97%) for potential biological applications. [¹³] </TD><TD VALIGN="TOP"> </TD><TD VALIGN="TOP"> (B) Regioselective syntheses of 2- and 4-formylpyrido[2,1-b]-­benzoxazoles (3 and 4, respectively) from diverse acetaminophenols 1 have been studied. [¹4] Surprisingly, reacting 1 with Vilsmeier reagent under Meth-Cohn conditions did not only yield expected aminoacroleins 2, but also pyridobenzoxazoles 3 as side products. Refluxing 2 with acetic anhydride afforded compounds 4 in good to moderate yields. Efficient synthesis of pyrido[2,1-b]benzoxazoles is of primary interest for their potential bioactivities. [¹5] </TD><TD VALIGN="TOP"> </TD><TD VALIGN="TOP"> (C) Phosphorus oxychloride has been used to promote Friedel-Crafts intramolecular cyclization from indole derivatives 1. [¹6] Pyrroloacridones 2 were obtained under mild conditions (POCl₃, 60 ˚C) whereas harsher ones resulted in the chlorination of the carbonyl followed by aromatization to give pyrroloacridines derivatives 3 in high yields (up to 91%). </TD><TD VALIGN="TOP"> </TD><TD VALIGN="TOP"> (D) P-Stereogenic heterocycles have been diastereoselectively synthesized from phosphorus oxychloride by ring-closing metathesis (RCM). [¹7] POCl₃ is submitted to O-alkylation followed by double nucleophilic additions on alkyne magnesium bromide derivatives to form organophosphinate 1. Diastereoselective enyne RCM in the presence of the Hoveyda catalyst afforded heterocycles 2 in high yields (>98%) and diastereoisomeric excess (18:1). </TD><TD VALIGN="TOP"> </TD><TD VALIGN="TOP"> (E) The synthesis of novel fused isoxazole and isoxazoline rings 2 by POCl₃-mediated intramolecular nitrile oxide cycloadditions (INOC) has been reported. [¹8] Compounds 1 synthesized by the Ugi reaction were submitted to INOC [2+3] addition in the presence of phosphorus oxychloride and triethylamine to afford a library of new heterocycles 2 in moderate yields (27-63%). </TD><TD VALIGN="TOP"> </TD><TD VALIGN="TOP"> (F) An unusual α-hydroxylation of γ-butyrolactone in the presence of phosphorus oxychloride has been described. [¹9] Compounds 1 obtained from chiral pool were submitted to POCl₃-mediated dehydration in the presence of pyridine at low temperature. A mechanism involving an enolization of the lactone followed by the formation of a POCl₃ cycloadduct is proposed. The hydroxyl intermediate is trapped with diazomethane to afford Quararibea metabolite analogues 2. </TD><TD VALIGN="TOP"> </TD><TD VALIGN="TOP"> (G) The Vilsmeier reagent has been selected to promote the synthesis of bis-β-lactam derivatives 3 by Staudinger cycloaddition. [²0] Bis-imines 1, prepared from the corresponding diamine and aldehydes, underwent a [2+2]-ketene-imine cycloaddition. Ketenes were generated in situ by action of the Vilsmeier reagent on the carboxylic acids 2. </TD><TD VALIGN="TOP"> </TD>

References

<A NAME="RV3621210TX-1">1</A> Sharma SD. Kanwar S. Indian J. Chem., Sect B: Org. Chem. Incl. Med. Chem.  1998,  37, 965 

<A NAME="RV3621210TX-2A">2a</A> Gensler WJ. Org. React.  1951,  74 

<A NAME="RV3621210TX-2B">2b</A> Awuah E. Capretta A. J. Org. Chem.  2010,  75:  5627 

<A NAME="RV3621210TX-3A">3a</A> Chrzanowska M. Rozwadowska MD. Chem. Rev.  2004,  104:  3341 

<A NAME="RV3621210TX-3B">3b</A> Bronstein HA. Finlayson CE. Kirov KR. Friend RH. Williams CK. Organometallics  2008,  27, 2980 

<A NAME="RV3621210TX-4A">4a</A> Meth-Cohn O. Heterocycles  1993,  35, 539 

<A NAME="RV3621210TX-4B">4b</A> Baruah B. Bhuyan PJ. Tetrahedron  2009,  65, 7099 

For examples, see:

<A NAME="RV3621210TX-5A">5a</A> Gammon DW. Hunter R. Seanette AW. Tetrahedron  2005,  61:  10683 

<A NAME="RV3621210TX-5B">5b</A> Miyake F. Hashimoto M. Tonsiengsom S. Yakushijin K. Horne DA. Tetrahedron  2010,  66, 4888 

For examples, see:

<A NAME="RV3621210TX-6A">6a</A> Cailly T. Begtrup M. Tetrahedron  2010,  66:  1299 

<A NAME="RV3621210TX-6B">6b</A> Shing TKM. Cheng HM. J. Org. Chem.  2010,  75, 3522 

<A NAME="RV3621210TX-7A">7a</A> Jones G. Stanforth SP. Org. React.  2001,  49:  1 

<A NAME="RV3621210TX-7B">7b</A> Quiroga J. Diaz Y. Insuasty B. Abonia R. Nogueras M. Cobo J. Tetrahedron Lett.  2010,  51:  2928 

For examples, see:

<A NAME="RV3621210TX-8A">8a</A> Yin Y. Zhang Q. Liu Q. Liu Y. Sun S. Synth. Commun.  2007,  37:  730 

<A NAME="RV3621210TX-8B">8b</A> Shavaev KV. Tandon SS. Dawe LN. Thompson LK. Chem. Commun.  2010,  46, 4755 

For examples, see:

<A NAME="RV3621210TX-9A">9a</A> Nayak SK. Arora S. Sindhu JS. Sangwan RB. Int. Dairy J.  2006,  16:  268 

<A NAME="RV3621210TX-9B">9b</A> Han J.-A. BeMiller JN. Carbohydr. Polym.  2008,  73:  532 

For examples, see:

<A NAME="RV3621210TX-10A">10a</A> Wridges CT. Timper J. Fischler M. Sologubenko AS. Mayer J. Simon U. Carell T. Angew. Chem. Int. Ed.  2009,  48:  219 

<A NAME="RV3621210TX-10B">10b</A> Liu M. Jinmei H. Abe H. Ito Y. Bioorg. Med. Chem. Lett.  2010,  20, 2964 

For examples, see:

<A NAME="RV3621210TX-11A">11a</A> Anwar E. Khotimah H. Yanuar A. J. Med. Sci.  2006,  6, 923 

<A NAME="RV3621210TX-11B">11b</A> Wang X. Hu Y. Song L. Xing W. Lu H. Lv P. Jie G. Polymer  2010,  51:  2435 

<A NAME="RV3621210TX-12">12</A> Zhang X. Lin Q. Zhong P. Molecules  2010,  15:  3079 

<A NAME="RV3621210TX-13A">13a</A> Gilbert AM. Nowak P. Brooijmans N. Bursavich MG. Dehnhardt C. Santos ED. Feldberg LR. Hollander I. Kim S. Lombardi S. Bioorg. Med. Chem. Lett.  2010,  20:  636 

<A NAME="RV3621210TX-13B">13b</A> Ghorab MM. Ragab FA. Alqasoumi SI. Alafeefy AM. Aboulmagd SA. Eur. J. Med. Chem.  2010,  45:  171 

<A NAME="RV3621210TX-14">14</A> Li K.-L. Du Z.-B. Guo C.-C. Chen Q.-Y. J. Org. Chem.  2009,  74:  3286 

<A NAME="RV3621210TX-15">15</A> Rida SM. Ashour FA. El-Hawash SAM. Elsemary SS. Badir MH. Shalaby MA. Eur. J. Med. Chem.  2005,  40:  949 

<A NAME="RV3621210TX-16">16</A> Meesala R. Nagarajan R. Tetrahedron Lett.  2010,  51:  422 

<A NAME="RV3621210TX-17">17</A> Harvey JS. Giuffredi GT. Gouverneur V. Org. Lett.  2010,  12, 1236 

<A NAME="RV3621210TX-18">18</A> Akritopoulou-Zanze I. Gracias V. Moore JD. Djuric SW. Tetrahedron Lett.  2004,  45:  3421 

<A NAME="RV3621210TX-19">19</A> Gopinath C. Thomas S. Nair MS. Ibnusaud I. Tetrahedron Lett.  2006,  47:  7957 

<A NAME="RV3621210TX-20">20</A> Meshram J. Ali P. Tiwari V. J. Heterocycl. Chem.  2010,  47:  1454